The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients

Breast

Volumn 22, Issue 6, 2013, Pages 1119-1124

  Korhonen, T ^a   Kuukasjarvi T ^b   Huhtala, H ^c   Alarmo, E L ^c   Holli, K ^c   Kallioniemi, A ^c   Pylkkanen L ^c,d  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b Medix Laboratoriot Oy   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Biology; Breast cancer; Cox regression analysis; Ductal; Lobular; Recurrence

Indexed keywords

ANTIESTROGEN; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ARTICLE; BONE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOLOGY; HISTOPATHOLOGY; HUMAN; LONG TERM SURVIVAL; LUNG METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN METASTASIS; SURVIVAL TIME; VISCERAL METASTASIS;

BIOLOGY; BREAST CANCER; COX-REGRESSION ANALYSIS; DUCTAL; LOBULAR; RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84887177075     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.06.001     Document Type: Article

References (30)

1. Arpino G., Bardou V.J., Clark G.M., Elledge R.M. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004, 6:R149-R156.
2. Pestalozzi B.C., Zahrieh D., Mallon E., Gusterson B.A., Price K.N., Gelber R.D., et al. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. JClin Oncol 2008, 26:3006-3014.
3. Rakha E.A., El-Sayed M.E., Powe D.G., Green A.R., Habashy H., Grainge M.J., et al. Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer 2008, 44:73-83.
4. Li C.I., Anderson B.O., Porter P., Holt S.K., Daling J.R., Moe R.E. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer 2000, 88:2561-2569.
5. Chen C.L., Weiss N.S., Newcomb P., Barlow W., White E. Hormone replacement therapy in relation to breast cancer. JAMA 2002, 287(6):734-741.
6. Daling J.R., Malone K.E., Doody D.R., Voigt L.F., Bernstein L., Coates R.J., et al. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer 2002, 95:2455-2464.
7. Li C.I., Malone K.E., Porter P.L., Weiss N.S., Tang M.T., Cushing-Haugen K.L., et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003, 289:3254-3263.
8. Reeves G.K., Beral V., Green J., Gathani T., Bull D., Million Women Study Collaborators Hormonal therapy for menopause and breast-cancer risk by histological type. Lancet Oncol 2006, 7(11):910-918.
9. Ravdin P.M. Hormone replacement therapy and the increase in the incidence of invasive lobular cancer. Breast Dis 2009, 30(1):3-8.
10. Sastre-Garau X., Jouve M., Asselain B., Vincent-Salomon A., Beuzeboc P., Dorval T., et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996, 77:113-120.
11. du Toit R.S., Locker A.P., Ellis I.O., Elston C.W., Nicholson R.I., Robertson J.F., et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol 1991, 17:251-257.
12. Cristofanilli M., Gonzalez-Angulo A., Sneige N., Kau S.W., Broglio K., Theriault R.L., et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. JClin Oncol 2005, 23:41-48.
13. Dian D., Herold H., Mylonas I., Scholz C., Janni W., Sommer H., et al. Survival analysis between patients with invasive ductal and invasive lobular breast cancer. Arch Gynecol Obstet 2009 Jan, 279(1):23-28.
14. Toikkanen S., Pylkkänen L., Joensuu H. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer 1997, 76:1234-1240.
15. Wasif N., Etzioni D., Maggard M.A., Tomlinson J.S., Ko C.Y. Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes. Ann Surg Oncol 2010, 17(7):1862-1869.
16. Korhonen T., Huhtala H., Holli K. Acomparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast. Breast Cancer Res Treat 2004 May, 85(1):23-29.
17. Gonzalez-Angulo A.M., Sahin A., Krishnamurthy S., Yang Y., Kau S.W., Hortobagyi G.N., et al. Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma. Clin Breast Cancer 2006 Dec, 7(5):396-400.
18. Molland J.G., Donnellan M., Janu N.C., Carmalt H.L., Kennedy C.W., Gillett D.J. Infiltrating lobular carcinoma-a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. Breast 2004, 13:389-396.
19. Viale G., Rotmensz N., Maisonneuve P., Orvieto E., Maiorano E., Galimberti V., et al. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series. Breast Cancer Res Treat 2009, 117:211-214.
20. Lesser M.L., Rosen P.P., Kinne D.W. Multicentrity and bilaterality in invasive breast carcinoma. Surgery 1982, 91:234-240.
21. Horn P.L., Thompson W.D. Risk of contralateral breast cancer. Associations with histologic, clinical, and therapeutic factors. Cancer 1988, 62:412-424.
22. Silverstein M.J., Lewinsky B.S., Waisman J.R., Gierson E.D., Colburn W.J., Senofsky G.M., et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?. Cancer 1994, 73:1673-1677.
23. Cserni G. Reproducibility of a diagnosis if invasive lobular carcinoma. JSurg Oncol 1999, 70:217-221.
24. Longacre T.A., Ennis M., Quenneville L.A., Bane A.L., Bleiweiss I.J., Carter B.A., et al. Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Mod Pathol 2006, 19:195-207.
25. Mate T.P., Carter D., Fischer D.B., Hartman P.V., McKhann C., Merino M., et al. Aclinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Cancer 1986, 58:1995-2002.
26. Harris E.E., Hwang R., Santiago R., Solin L.J. Long-term outcomes for breast conservation therapy in invasive lobular carcinoma of the breast. Int J Radiat Oncol Biol Phys 2003, 57(Suppl.):S359-S360.
27. Lamovec J., Bracko M. Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study. JSurg Oncol 1991, 48:28-33.
28. Mathieu M.C., Rouzier R., Llombart-Cussac A., Sideris L., Koscielny S., Travagli J.P., et al. The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer 2004, 342-351.
29. Cocquyt V., Van Belle S. Lobular carcinoma in situ and invasive lobular cancer of the breast. Curr Opin Obstet Gynecol 2005, 17:55-60.
30. Tubiana-Hulin M., Stevens D., Lasry S., Guinebretière J.M., Bouita L., Cohen-Solal C., et al. Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. Ann Oncol 2006, 17:1228-1233.